World's Best Scientists 2026 revealed!
Juan González-Lahoz

Juan González-Lahoz

D-Index & Metrics

Immunology

D-Index
64
Citations
17358
World Ranking
2910
National Ranking
30

Juan González-Lahoz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Juan González-Lahoz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 318 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Juan González-Lahoz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Juan González-Lahoz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Juan González-Lahoz is affiliated with the Instituto de Salud Carlos III in Spain. This association places them within a significant Spanish public research institution specialized in health sciences and biomedical research, contributing to national and international scientific advancements.

The scholar's work spans multiple aspects of their domain, although specific papers, frequent co-authors, and publication venues have not been documented here. This limits detailed insight into the scientist's collaborative network or publication patterns but does not diminish the institutional context that supports their scientific endeavors.

Details about main fields or subfields of study have not been specified. Similarly, information on primary topics or thematic foci of González-Lahoz's research is unavailable, so the precise areas of specialization within health sciences or related disciplines remain unspecified in this profile.

There is no record of book publications or awards attributed to this researcher. Thus, no information concerning extended scholarly contributions through books or formal recognitions can be presented at this time.

Juan González-Lahoz is currently active in the scientific community. The profile is constructed with neutral language and relies exclusively on available data to ensure accuracy and factual reporting without interpretative bias.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.

    V Gordillo;J del Amo;V Soriano;J González-Lahoz

  • Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus

    Juan Berenguer;Santiago Moreno;Fernando Laguna;Teresa Vicente

  • Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients.

    Luz Martín-Carbonero;Vincent Soriano;Eulalia Valencia;Javier García-Samaniego

  • Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter

    David A. Cooper;Jose M. Gatell;Susanne Kroon;Nathan Clumeck

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users

    V. Soriano;J. García-samaniego;E. Valencia;R. Rodríguez-rosado

  • Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.

    P. Barreiro;V. Soriano;F. Blanco;C. Casimiro

  • Interferon α for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus

    V Soriano;J García-Samaniego;R Bravo;J González

  • Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

    Sonia Rodriguez-Novoa;Pablo Barreiro;Ana Rendón;Inmaculada Jiménez-Nacher

  • Severe liver disease associated with prolonged exposure to antiretroviral drugs.

    Ivana Maida;Marina Núñez;Maria Jose Ríos;Luz Martín-Carbonero

  • Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.

    Sonia Rodríguez-Nóvoa;Luz Martín-Carbonero;Pablo Barreiro;Gema González-Pardo

  • Analyzing Sleep Abnormalities in HIV-Infected Patients Treated with Efavirenz

    Lucía Gallego;Pablo Barreiro;Rafael del Río;Daniel González de Requena

  • Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.

    V. Soriano;C. Dona;R. Rodríguez-Rosado;P. Barreiro

  • Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.

    Pablo Barreiro;Jorge del Romero;Manuel Leal;Victoria Hernando

  • Higher efavirenz plasma levels correlate with development of insomnia.

    Marina Núñez;Daniel González de Requena;Lucía Gallego;Inmaculada Jiménez-Nácher

  • Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.

    Vincent Soriano;Perpétua Gomes;Walid Heneine;Africa Holguín

  • Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.

    Luz Martín-Carbonero;Marina Núñez;Juan González-Lahoz;Vincent Soriano

  • Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

    Marina Núñez;Mayte Pérez-Olmeda;Beatriz Díaz;Pilar Ríos

  • Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.

    Luz Martin-Carbonero;Ana Barrios;Pere Saballs;Guillem Sirera

  • Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C→T Polymorphism at the Multidrug Resistance Gene 1

    Sonia Rodríguez Nóvoa;Pablo Barreiro;Ana Rendón;Ana Barrios

Frequent Co-Authors

Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Pablo Barreiro
Pablo Barreiro Hospital Universitario La Paz
Luz Martín-Carbonero
Luz Martín-Carbonero Hospital Universitario La Paz
Javier García-Samaniego
Javier García-Samaniego Hospital Universitario La Paz
Marina Núñez
Marina Núñez Wake Forest University
Francisco J. Blanco
Francisco J. Blanco University of A Coruña
Carmen de Mendoza
Carmen de Mendoza Instituto de Salud Carlos III
Pablo Labarga
Pablo Labarga Instituto de Salud Carlos III
Nathan Clumeck
Nathan Clumeck Université Libre de Bruxelles
José M. Gatell
José M. Gatell University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, related healthcare fields such as nursing offer numerous online degree options that provide flexibility and specialized training. One popular choice is exploring the cheapest psych np programs online, which can open doors to mental health services and integrative care involving immune system research.

Advancing your career in nursing often comes with financial benefits. Understanding how much do dnp nurses make by state can help guide your educational investments and career planning, especially when considering specialized roles in immunology-related fields.

For those already working as Family Nurse Practitioners, obtaining an acute care np certification offers a pathway to managing complex patient cases with immune system involvement, such as autoimmune diseases or transplant care.

Finally, exploring an accelerated nurse practitioner program can provide a faster route to entering advanced practice nursing, making this an appealing option for those eager to begin careers intersecting with immunological research and patient care.

Best Scientists Citing Juan González-Lahoz

Recently Published Articles